Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acquired Hyperostosis Syndrome | 32 | 2022 | 34 | 6.500 |
Why?
|
| Osteitis | 10 | 2022 | 32 | 1.740 |
Why?
|
| Hyperostosis | 7 | 2022 | 29 | 1.170 |
Why?
|
| Spine | 6 | 2021 | 1128 | 1.150 |
Why?
|
| Synovitis | 7 | 2022 | 209 | 1.050 |
Why?
|
| Acne Vulgaris | 8 | 2022 | 352 | 0.940 |
Why?
|
| Joint Deformities, Acquired | 1 | 2021 | 35 | 0.720 |
Why?
|
| Radionuclide Imaging | 6 | 2020 | 1978 | 0.710 |
Why?
|
| Clavicle | 1 | 2021 | 224 | 0.610 |
Why?
|
| Sacroiliac Joint | 1 | 2018 | 58 | 0.600 |
Why?
|
| Whole Body Imaging | 1 | 2019 | 281 | 0.550 |
Why?
|
| Bone and Bones | 5 | 2022 | 2554 | 0.510 |
Why?
|
| Thoracic Wall | 2 | 2020 | 197 | 0.300 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4209 | 0.290 |
Why?
|
| Drugs, Chinese Herbal | 2 | 2020 | 142 | 0.280 |
Why?
|
| Diphosphonates | 3 | 2020 | 625 | 0.250 |
Why?
|
| Blood Sedimentation | 3 | 2021 | 233 | 0.240 |
Why?
|
| Tripterygium | 3 | 2021 | 16 | 0.230 |
Why?
|
| Piperidines | 3 | 2021 | 1664 | 0.210 |
Why?
|
| Psoriasis | 3 | 2021 | 919 | 0.210 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2023 | 107 | 0.200 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2022 | 86 | 0.190 |
Why?
|
| Tonsillectomy | 2 | 2021 | 284 | 0.180 |
Why?
|
| Tonsillitis | 1 | 2021 | 28 | 0.180 |
Why?
|
| Nail Diseases | 1 | 2021 | 54 | 0.170 |
Why?
|
| Jaw Diseases | 1 | 2021 | 91 | 0.170 |
Why?
|
| Glycosides | 1 | 2020 | 99 | 0.170 |
Why?
|
| Pyrimidines | 3 | 2021 | 3047 | 0.170 |
Why?
|
| Mandible | 2 | 2021 | 746 | 0.160 |
Why?
|
| Time | 1 | 2021 | 550 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2022 | 408 | 0.150 |
Why?
|
| Methylprednisolone | 1 | 2019 | 386 | 0.140 |
Why?
|
| Arthritis, Psoriatic | 1 | 2020 | 216 | 0.140 |
Why?
|
| Acromegaly | 1 | 2020 | 316 | 0.140 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2019 | 157 | 0.140 |
Why?
|
| Students, Medical | 2 | 2023 | 1959 | 0.140 |
Why?
|
| Self Disclosure | 1 | 2018 | 248 | 0.140 |
Why?
|
| Mobility Limitation | 1 | 2021 | 408 | 0.140 |
Why?
|
| Arthralgia | 1 | 2021 | 459 | 0.130 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2021 | 1094 | 0.130 |
Why?
|
| Remission Induction | 5 | 2021 | 2411 | 0.130 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15880 | 0.130 |
Why?
|
| Fibromyalgia | 1 | 2020 | 406 | 0.130 |
Why?
|
| Spinal Diseases | 1 | 2020 | 559 | 0.120 |
Why?
|
| Burnout, Professional | 1 | 2023 | 711 | 0.120 |
Why?
|
| Prednisone | 1 | 2019 | 1565 | 0.120 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 3850 | 0.110 |
Why?
|
| China | 4 | 2023 | 2385 | 0.110 |
Why?
|
| Pyrroles | 1 | 2020 | 1119 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 2018 | 783 | 0.100 |
Why?
|
| Professional-Patient Relations | 1 | 2018 | 721 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2021 | 20659 | 0.100 |
Why?
|
| Humans | 40 | 2023 | 765968 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 1 | 2019 | 791 | 0.090 |
Why?
|
| Biological Products | 1 | 2020 | 942 | 0.090 |
Why?
|
| Internship and Residency | 2 | 2023 | 5946 | 0.090 |
Why?
|
| Education, Medical | 1 | 2023 | 1746 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2132 | 0.080 |
Why?
|
| Middle Aged | 13 | 2021 | 223009 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 2136 | 0.080 |
Why?
|
| Radiology | 1 | 2023 | 2090 | 0.080 |
Why?
|
| Adult | 16 | 2021 | 223044 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 2024 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4642 | 0.080 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 1365 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2268 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 2067 | 0.070 |
Why?
|
| Male | 16 | 2021 | 363698 | 0.070 |
Why?
|
| Echocardiography | 1 | 2020 | 5045 | 0.070 |
Why?
|
| General Surgery | 1 | 2019 | 1722 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4528 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2023 | 4863 | 0.070 |
Why?
|
| Female | 19 | 2021 | 396112 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4348 | 0.070 |
Why?
|
| Neutrophils | 1 | 2019 | 3776 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12976 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 4034 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5696 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9525 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 36532 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2021 | 65188 | 0.050 |
Why?
|
| Prevalence | 3 | 2023 | 15842 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2023 | 651 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2020 | 295 | 0.040 |
Why?
|
| Off-Label Use | 1 | 2020 | 185 | 0.040 |
Why?
|
| Osteolysis | 1 | 2020 | 271 | 0.040 |
Why?
|
| Skull | 1 | 2022 | 811 | 0.040 |
Why?
|
| Edema | 1 | 2021 | 760 | 0.040 |
Why?
|
| Nails | 1 | 2019 | 298 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2021 | 8733 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2021 | 81514 | 0.030 |
Why?
|
| Head | 1 | 2022 | 925 | 0.030 |
Why?
|
| Gadolinium | 1 | 2021 | 965 | 0.030 |
Why?
|
| Ligands | 1 | 2023 | 3273 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2021 | 54802 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 26318 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15398 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 2210 | 0.030 |
Why?
|
| Trust | 1 | 2018 | 533 | 0.030 |
Why?
|
| Disease Progression | 2 | 2020 | 13632 | 0.030 |
Why?
|
| Psychometrics | 1 | 2023 | 3062 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1481 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2021 | 2921 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2019 | 1354 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 4015 | 0.020 |
Why?
|
| Age of Onset | 1 | 2018 | 3344 | 0.020 |
Why?
|
| Aged | 5 | 2021 | 171117 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2021 | 3561 | 0.020 |
Why?
|
| Medical Errors | 1 | 2018 | 1260 | 0.020 |
Why?
|
| Radiography | 1 | 2020 | 6919 | 0.020 |
Why?
|
| Young Adult | 3 | 2021 | 59889 | 0.020 |
Why?
|
| Child | 3 | 2022 | 80564 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39193 | 0.020 |
Why?
|
| Myocardium | 1 | 2021 | 4760 | 0.020 |
Why?
|
| Contrast Media | 1 | 2021 | 5329 | 0.020 |
Why?
|
| Adolescent | 3 | 2022 | 88835 | 0.020 |
Why?
|
| Cytokines | 1 | 2023 | 7421 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4489 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20124 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12768 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22223 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10850 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29922 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24282 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13462 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40065 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41649 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 74840 | 0.010 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_